You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | n/a |
Div Cover | n/a | n/a |
Op Mrgn | -8.2% | n/a |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -16.4 | n/a |
PEG | 0.0 | n/a |
Price / Revenue | 1.9 | n/a |
Price / Book value | 1.5 |
Latest | Forecast | |
---|---|---|
Revenue | 23.9% | 17.6% |
PBT | 0.0% | n/a |
EPS | 0.0% | -185.6% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-12-31 | 11.62 | -8.88 | -70.00p | -9.3 | 0.0 | n/a | n/a | 0.0% |
2019-12-31 | 13.03 | -7.66 | -60.00p | -1.7 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 16.47 | -13.15 | $-0.28 | -2.6 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 19.75 | -5.14 | $-0.07 | -10.3 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 24.48 | -2.83 | $-0.04 | -17.1 | 0.0 | n/a | n/a | 0.0% |
Tissue Regenix signs exclusive distribution deal in China Sharecast News | 18 Jan |
---|
Director/PDMR Shareholding | 15-Sep-23 23:59 |
---|---|
New sports medicine product launch | 05-Sep-23 14:10 |
Interim results | 05-Sep-23 14:08 |
Exercise of Options and Total Voting Rights | 31-Aug-23 22:32 |
Notice of interim results | 21-Aug-23 14:12 |